These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27644954)

  • 1. Elevated serum levels of interleukin-1β and interleukin-33 in patients with systemic sclerosis in Chinese population.
    Zhang YJ; Zhang Q; Yang GJ; Tao JH; Wu GC; Huang XL; Duan Y; Li XP; Ye DQ; Wang J
    Z Rheumatol; 2018 Mar; 77(2):151-159. PubMed ID: 27644954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of interleukin-1α in patients with systemic sclerosis.
    Maekawa T; Jinnin M; Ohtsuki M; Ihn H
    J Dermatol; 2013 Feb; 40(2):98-101. PubMed ID: 23078215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
    Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis.
    Lin E; Vincent FB; Sahhar J; Ngian GS; Kandane-Rathnayake R; Mende R; Morand EF; Lang T; Harris J
    Clin Transl Immunology; 2019; 8(4):e1045. PubMed ID: 30997045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
    Sato S; Hasegawa M; Takehara K
    J Dermatol Sci; 2001 Oct; 27(2):140-6. PubMed ID: 11532378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17, IL-6 and IFN-γ in Systemic Sclerosis Patients.
    Bălănescu P; Lădaru A; Bălănescu E; Nicolau A; Băicuş C; Dan GA
    Rom J Intern Med; 2015; 53(1):44-9. PubMed ID: 26076560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
    Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
    Front Immunol; 2018; 9():1250. PubMed ID: 29930551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
    Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
    Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
    Hasegawa M; Fujimoto M; Kikuchi K; Takehara K
    J Rheumatol; 1997 Feb; 24(2):328-32. PubMed ID: 9034992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis.
    Abtahi S; Farazmand A; Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Nazari B; Kavosi H; Amirzargar AA; Jamshidi AR; Gharibdoost F
    Int J Immunogenet; 2015 Dec; 42(6):423-7. PubMed ID: 26416393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
    Hasegawa M; Sato S; Takehara K
    Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interleukin-2 and interleukin-6 in serum as markers of disease progression in systemic sclerosis].
    Lis A; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2001 Sep; 11(63):206-9. PubMed ID: 11761811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
    Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
    Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of interleukin 17 and 22 in patients with systemic sclerosis: a single-center cross-sectional study.
    Kardum Ž; Milas-Ahić J; Šahinović I; Masle AM; Uršić D; Kos M
    Rheumatol Int; 2023 Feb; 43(2):345-354. PubMed ID: 36416900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis.
    Xu W; Su L; Qing P; Wang Y; Liang Y; Zhao Y; Zhou Q; Ma F; Liu Y
    Clin Rheumatol; 2017 Jun; 36(6):1317-1324. PubMed ID: 28397078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement.
    Dantas AT; Gonçalves SM; Pereira MC; Gonçalves RS; Marques CD; Rego MJ; Pitta Ida R; Duarte AL; Pitta MG
    Clin Rheumatol; 2015 Sep; 34(9):1621-5. PubMed ID: 26160266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
    van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
    Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.